July 19, 2023 July 19, 2023Categories Editorials7 ways advocates have enhanced ECOG-ACRIN’s cancer research programECOG-ACRIN’s cancer research advocates recently reflected on their committee’s key accomplishments
July 19, 2023 July 19, 2023Categories New TrialsNow Enrolling: The DIRECT study is testing how well FDG-PET/CT imaging can predict if treatment is working prior to surgery for patients with HER2-positive breast cancerThis study is for patients who have untreated, early-stage HER2-positive breast cancer
July 19, 2023 July 19, 2023Categories New TrialsNow Enrolling: ComboMATCH treatment trial E4 is testing a new option for patients with advanced solid tumors that progress despite taxane chemotherapyThis study is for patients with solid tumors that are progressing after treatment with taxane therapies
July 19, 2023 July 19, 2023Categories Ongoing TrialsA closer look at ECOG-ACRIN’s men’s cancer trialsThese trials are exploring new treatment approaches for adults with prostate or penile cancer